{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:37Z","timestamp":1787020657268,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Congestive heart failure (CHF) is a major cause of the development of progressive chronic kidney disease (CKD), while the mechanism is still unknown. LncRNA PVT1 contributes to kidney injury. This study aimed to explore the role of PVT1 in the development of CKD in CHF patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Expression of PVT1 in plasma samples of CHF patients with and without CKD was determined by RT-qPCR. The diagnostic value of plasma PVT1 for CKD was evaluated by ROC curve analysis. The predictive value of PVT1 for the development of CKD in CHF patients was analyzed by a 2-year follow-up study. Changes in PVT1 expression in CKD patients during treatment were analyzed by RT-qPCR and reflected by heatmaps.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma PVT1 was downregulated in CHF and further downregulated in CHF patients complicated with progressive CKD. ROC curve analysis showed that plasma PVT1 levels could be used to distinguish CHF patients complicated with CKD from CHF patients without CKD and healthy controls. During a 2-year follow-up, patients with high CHF levels had a low incidence of progressive CKD among CHF patients. Moreover, with the treatment of progressive CKD, plasma PVT1 was upregulated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>LncRNA-PVT1 downregulation may participate in the development of progressive CKD among patients with CHF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12950-021-00293-5","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T18:02:33Z","timestamp":1632592953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Downregulation of lncRNA-PVT1 participates in the development of progressive chronic kidney disease among patients with congestive heart failure"],"prefix":"10.1186","volume":"18","author":[{"given":"Yingwei","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-9907","authenticated-orcid":false,"given":"Yaguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"issue":"S2","key":"293_CR1","first-page":"14","volume":"4","author":"GS Francis","year":"2019","unstructured":"Francis GS, Tang WHW. Pathophysiology of congestive heart failure. Rev Cardiovasc Med. 2019;4(S2):14\u201320.","journal-title":"Rev Cardiovasc Med"},{"issue":"7","key":"293_CR2","doi-asserted-by":"publisher","first-page":"e665","DOI":"10.1016\/S2214-109X(17)30196-1","volume":"5","author":"H Dokainish","year":"2017","unstructured":"Dokainish H, Teo K, Zhu J, et al. Global mortality variations in patients with heart failure: results from the international congestive heart failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017;5(7):e665\u201372.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"293_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.7326\/0003-4819-156-11-201206050-00003","volume":"156","author":"DS Lee","year":"2012","unstructured":"Lee DS, Stitt A, Austin PC, et al. Prediction of heart failure mortality in emergent care: a cohort study. Ann Intern Med. 2012;156(11):767\u201375.","journal-title":"Ann Intern Med"},{"issue":"3","key":"293_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1037\/hea0000271","volume":"35","author":"CL Park","year":"2016","unstructured":"Park CL, Aldwin CM, Choun S, et al. Spiritual peace predicts 5-year mortality in congestive heart failure patients. Health Psychol. 2016;35(3):203\u201310.","journal-title":"Health Psychol"},{"issue":"31","key":"293_CR5","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","volume":"34","author":"B Pitt","year":"2013","unstructured":"Pitt B, Kober L, Ponikowski P, et al. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J. 2013;34(31):2453\u201363.","journal-title":"Eur Heart J"},{"issue":"5","key":"293_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442\u20138.","journal-title":"Kidney Int"},{"issue":"10","key":"293_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","volume":"12","author":"JC Schefold","year":"2016","unstructured":"Schefold JC, Filippatos G, Hasenfuss G, et al. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol. 2016;12(10):610\u201323.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"293_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.118.12261","volume":"73","author":"L Santer","year":"2019","unstructured":"Santer L, L\u00f3pez B, Ravassa S, et al. Circulating long noncoding RNA LIPCAR predicts heart failure outcomes in patients without chronic kidney disease. Hypertension. 2019;73(4):820\u20138.","journal-title":"Hypertension."},{"issue":"6","key":"293_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrneph.2016.51","volume":"12","author":"JM Lorenzen","year":"2016","unstructured":"Lorenzen JM, Thum T. Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol. 2016;12(6):360\u201373.","journal-title":"Nat Rev Nephrol."},{"key":"293_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.vph.2018.01.003","volume":"114","author":"V Simion","year":"2019","unstructured":"Simion V, Haemmig S, Feinberg MW. LncRNAs in vascular biology and disease. Vasc Pharmacol. 2019;114:145\u201356.","journal-title":"Vasc Pharmacol"},{"issue":"9","key":"293_CR11","doi-asserted-by":"publisher","first-page":"eaao2110","DOI":"10.1126\/sciadv.aao2110","volume":"3","author":"Y Long","year":"2017","unstructured":"Long Y, Wang X, Youmans DT, et al. How do lncRNAs regulate transcription? Sci Adv. 2017;3(9):eaao2110.","journal-title":"Sci Adv"},{"key":"293_CR12","doi-asserted-by":"publisher","first-page":"117340","DOI":"10.1016\/j.lfs.2020.117340","volume":"254","author":"W Huang","year":"2020","unstructured":"Huang W, Li X, Wang D, et al. Curcumin reduces LPS-induced septic acute kidney injury through suppression of lncRNA PVT1 in mice. Life Sci. 2020;254:117340.","journal-title":"Life Sci"},{"key":"293_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.intimp.2017.03.030","volume":"47","author":"W Huang","year":"2017","unstructured":"Huang W, Lan X, Li X, et al. Long non-coding RNA PVT1 promote LPS-induced septic acute kidney injury by regulating TNF\u03b1 and JNK\/NF-\u03baB pathways in HK-2 cells. Int Immunopharmacol. 2017;47:134\u201340.","journal-title":"Int Immunopharmacol"},{"issue":"55","key":"293_CR14","doi-asserted-by":"publisher","first-page":"31725","DOI":"10.1039\/C8RA05724A","volume":"8","author":"X Zhu","year":"2018","unstructured":"Zhu X, Shi J, Chen F. PVT1 knockdown alleviates vancomycin-induced acute kidney injury by targeting miR-124 via inactivation of NF-\u03baB signaling. RSC Adv. 2018;8(55):31725\u201334.","journal-title":"RSC Adv"},{"issue":"1\u20132","key":"293_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cccn.2004.01.028","volume":"343","author":"S Kr\u00fcger","year":"2004","unstructured":"Kr\u00fcger S, Kunz D, Graf J, et al. Endotoxin sensitivity and immune competence in chronic heart failure. Clin Chim Acta. 2004;343(1\u20132):135\u20139.","journal-title":"Clin Chim Acta"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-021-00293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12950-021-00293-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-021-00293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T18:10:20Z","timestamp":1632593420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal-inflammation.biomedcentral.com\/articles\/10.1186\/s12950-021-00293-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1186\/s12950-021-00293-5","relation":{},"ISSN":["1476-9255"],"issn-type":[{"value":"1476-9255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"31 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study. All producers were approved by the Ethics Committee of Affiliated Hospital of Shaoxing College of Arts and Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest. We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}